Atypical diaphyseal femur fractures in patients with prolonged administration of bisphosphonate medication for osteoporosis.
The Division of Orthopedic Surgery, Albany Medical Center, Albany, New York, USA.
Joel A
JA
Horning
John
J
Czajka
Richard L
RL
Uhl
D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use*; D005264:Femoral Fractures / Q000139:chemically induced* / Q000517:prevention & control*; D006801:Humans; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D058866:Osteoporotic Fractures / Q000139:chemically induced* / Q000517:prevention & control*
D050071:Bone Density Conservation Agents; D004164:Diphosphonates